Skip to main content

Teva to return rights to experimental cancer therapy

Teva Pharmaceutical Industries Ltd. is returning to OncoGenex the rights to a cancer drug, on which the companies had previously collaborated...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.